TOFACITINIB
NDC 59651-459, TOFACITINIB, tablet, film coated, from Aurobindo Pharma Limited.
- Product NDC
- 59651-459
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215356
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-459 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE5 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-459-60 | 59651045960 | 60 TABLET, FILM COATED in 1 BOTTLE (59651-459-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/50962b08-99dd-ae73-e063-6394a90ad1ebNADAC price for package 59651045960
GET /v1/drugs/nadac/59651045960
Use it
Look up 59651-459 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-459 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-459. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.